Zhang H - Search Results

1

Single dual-specific anti-PD-L1/TGF-β antibody synergizes with chemotherapy as neoadjuvant treatment for pancreatic ductal adenocarcinoma: a preclinical experimental study.

Zhang H, Chen J, Bai J, Zhang J, Huang S, Zeng L, Zhou P, Shen Q, Yin T. Zhang H, et al. Among authors: zhang j. Int J Surg. 2024 May 1;110(5):2679-2691. doi: 10.1097/JS9.0000000000001226. Int J Surg. 2024. PMID: 38489548 Free PMC article.

2

A novel staging system and clinical predictive nomogram for more accurate staging and prognosis of malignant pancreatic intraductal papillary mucinous neoplasms: a population-based study.

Zhang H, Gao C, Chen J, Wu S, Bai J, Yin T. Zhang H, et al. J Transl Med. 2021 Dec 24;19(1):525. doi: 10.1186/s12967-021-03188-4. J Transl Med. 2021. PMID: 34952605 Free PMC article.

3

Hyperglycemia Enhances Immunosuppression and Aerobic Glycolysis of Pancreatic Cancer Through Upregulating Bmi1-UPF1-HK2 Pathway.

Wu S, Zhang H, Gao C, Chen J, Li H, Meng Z, Bai J, Shen Q, Wu H, Yin T. Wu S, et al. Among authors: zhang h. Cell Mol Gastroenterol Hepatol. 2022;14(5):1146-1165. doi: 10.1016/j.jcmgh.2022.07.008. Epub 2022 Jul 19. Cell Mol Gastroenterol Hepatol. 2022. PMID: 35863742 Free PMC article.

4

METTL3 promotes pancreatic cancer proliferation and stemness by increasing stability of ID2 mRNA in a m6A-dependent manner.

Chen J, Zhang H, Xiu C, Gao C, Wu S, Bai J, Shen Q, Yin T. Chen J, et al. Among authors: zhang h. Cancer Lett. 2023 Jul 1;565:216222. doi: 10.1016/j.canlet.2023.216222. Epub 2023 May 19. Cancer Lett. 2023. PMID: 37196908

5

Adjustable extracellular matrix rigidity tumor model for studying stiffness dependent pancreatic ductal adenocarcinomas progression and tumor immunosuppression.

Zhang H, Chen J, Hu X, Bai J, Yin T. Zhang H, et al. Bioeng Transl Med. 2023 Apr 5;8(3):e10518. doi: 10.1002/btm2.10518. eCollection 2023 May. Bioeng Transl Med. 2023. PMID: 37206224 Free PMC article.

6

High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment.

Gao C, Chen J, Bai J, Zhang H, Tao Y, Wu S, Li H, Wu H, Shen Q, Yin T. Gao C, et al. Among authors: zhang h. J Transl Med. 2023 Jul 11;21(1):461. doi: 10.1186/s12967-023-04302-4. J Transl Med. 2023. PMID: 37434177 Free PMC article.

7

Targeting cytokine and chemokine signaling pathways for cancer therapy.

Yi M, Li T, Niu M, Zhang H, Wu Y, Wu K, Dai Z. Yi M, et al. Among authors: zhang h. Signal Transduct Target Ther. 2024 Jul 22;9(1):176. doi: 10.1038/s41392-024-01868-3. Signal Transduct Target Ther. 2024. PMID: 39034318 Free PMC article. Review.

8

Editorial: Investigating tumor immunotherapy responses in lung cancer using deep learning.

Qin S, Zhang H, Liu C, Yi M. Qin S, et al. Among authors: zhang h. Front Immunol. 2024 Dec 3;15:1529949. doi: 10.3389/fimmu.2024.1529949. eCollection 2024. Front Immunol. 2024. PMID: 39691722 Free PMC article. No abstract available.

9

Interfacial Engineering with a Conjugated Conductive Polymer for a Highly Reversible Zn Anode.

Zhang R, Song M, Zhang W, Shao A, Zhang L, Zhang H, Chao D, Zhou W. Zhang R, et al. Among authors: zhang h. ACS Appl Mater Interfaces. 2025 Jan 16. doi: 10.1021/acsami.4c18774. Online ahead of print. ACS Appl Mater Interfaces. 2025. PMID: 39818721

10

Unveiling the role of MDH1 in breast cancer drug resistance through single-cell sequencing and schottenol intervention.

Lu J, Ding F, Sun Y, Zhao Y, Ma W, Zhang H, Shi B. Lu J, et al. Among authors: zhang h. Cell Signal. 2025 Jan 14:111608. doi: 10.1016/j.cellsig.2025.111608. Online ahead of print. Cell Signal. 2025. PMID: 39818404

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

130,014 results

Search Page

Filters